Celldex Therapeutics reported $15K in Gross Profit on Sales for its fiscal quarter ending in March of 2026.





Gross Profit On Sales Change Date
AbbVie USD 14.39B 1.85B Jun/2026
Agenus USD 33.74M 468K Mar/2026
Amgen USD 5.87B 1.02B Mar/2026
Bristol-Myers Squibb USD 9.26B 1.19B Jun/2026
Celldex Therapeutics USD 15K 106K Mar/2026
Glaxosmithkline GBP 5.75B 2.99B Mar/2026
Nektar Therapeutics USD 10.86M 10.95M Mar/2026
Pfizer USD -248M 11.29B Jun/2026
Rigel Pharmaceuticals USD 28.49M 7.01M Jun/2024
Roche Holding CHF 22.69B 600M Jun/2026